References
- Andreasen R., Christensen C. K., Mogensen C. E. The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolite products. Acta Pharmacol. Toxicol. 1981; 49: 223–2291. Andreasen R., Christensen C. K., Mogensen C. E. The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolite products. Acta Pharmacol. Toxicol. 1981; 49: 223–229
- Heimsoth V., Loew D., Schuster O. Pharmacodynamics and pharmacokinetics of furosemide-retard and furosemide-retard/triamterene. Eur. J. Drug Me tab. Pharmacokinet. 1988; 13: 161–1642. Heimsoth V., Loew D., Schuster O. Pharmacodynamics and pharmacokinetics of furosemide-retard and furosemide-retard/triamterene. Eur. J. Drug Me tab. Pharmacokinet. 1988; 13: 161–164
- Diuretika2. Auflage., D. Loew, V. Heimsoth, E. Kuntz, H. Schilcher. Thieme, Stuttgart 19903. Diuretika2. Auflage., D. Loew, V. Heimsoth, E. Kuntz, H. Schilcher. Thieme, Stuttgart 1990
- Overdiek H. W. P. M., Hermens W. A. J. J., Merkus F. W. H. M. Determination of the serum concentration of spironolacton and its metabolites by high-performance liquid chromatography./. Chromatogr. 1985; 341: 279–2854. Overdiek H. W. P. M., Hermens W. A. J. J., Merkus F. W. H. M. Determination of the serum concentration of spironolacton and its metabolites by high-performance liquid chromatography./. Chromatogr. 1985; 341: 279–285
- Overdiek H. W. P. M., Hermens W. A. J. J., Merkus E. W. H. M. New insights into the pharmacokinetics of spironolactone. Clin. Pharmacol. Then 1985; 38: 469–4745. Overdiek H. W. P. M., Hermens W. A. J. J., Merkus E. W. H. M. New insights into the pharmacokinetics of spironolactone. Clin. Pharmacol. Then 1985; 38: 469–474
- Schuster O., Loew D., Knoell H. E. Bioavailability and elimination kinetics of the combination of furosemide-retard/triamterene. Eur. J. Drug Metab. Pharmacokinet. 1985; 10: 127–1326. Schuster O., Loew D., Knoell H. E. Bioavailability and elimination kinetics of the combination of furosemide-retard/triamterene. Eur. J. Drug Metab. Pharmacokinet. 1985; 10: 127–132
- Smith D. E., Lin E. T., Benet L. Z. Absorption of furosemide in healthy volunteers, measured with a metabolite-specific assay. Drug Metab. Disp. 1980; 8: 337–3427. Smith D. E., Lin E. T., Benet L. Z. Absorption of furosemide in healthy volunteers, measured with a metabolite-specific assay. Drug Metab. Disp. 1980; 8: 337–342
- Steinijans V. W., Diletti E. Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals. Eur. J. Clin. Pharmacol. 1983; 24: 127–1368. Steinijans V. W., Diletti E. Statistical analysis of bioavailability studies: parametric and nonparametric confidence intervals. Eur. J. Clin. Pharmacol. 1983; 24: 127–136